Pfizer reported $10.02B in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
AbbVie USD 5.31B 178M Sep/2026
Abbott USD 7.34B 22M Sep/2026
ALKERMES USD 261.1M 37.86M Sep/2026
Amgen USD 6.39B 169M Sep/2026
AstraZeneca USD 6.93B 362M Jun/2026
Bayer EUR 11.97B 43M Jun/2026
Biogen USD 2.22B 159.9M Sep/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Coherus Biosciences USD 5.67M 842K Jun/2026
Drreddys Laboratories INR 81.18B 4.65B Sep/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Gilead Sciences USD 1.9B 57M Sep/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
Glaxosmithkline GBP 6.3B 143M Sep/2026
J&J USD 15.38B 233M Sep/2026
Medtronic USD 6.22B 264M Jun/2026
Merck USD 6.16B 43M Sep/2026
Neurocrine Biosciences USD 66.1M 38.1M Sep/2026
Novartis USD 6.1B 116M Sep/2026
Novartis USD 6.1B 182M Sep/2026
Pacira USD 3.83B 3.69B Sep/2026
Perrigo USD 1.01B 50.7M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Phibro Animal Health USD 567.14M 32.26M Sep/2026
Prestige Brands USD 179.2M 11.01M Sep/2026
Regeneron Pharmaceuticals USD 2.89B 189.7M Sep/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
Sanofi EUR 24.12B 620M Jun/2026
Vertex Pharmaceuticals USD 2.25B 480.2M Sep/2026
Zoetis USD 2.54B 38M Sep/2026